Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annemijn P A Wierenga

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cancers|August 10, 2019
HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological TargetZahra Souri, Annemijn P A Wierenga, Arend Mulder, et al.
International Journal of Molecular Sciences|October 1, 2020
Iris Colour and the Risk of Developing Uveal MelanomaLaurien E Houtzagers, Annemijn P A Wierenga, Aleid A M Ruys, et al.
Ocular Oncology and Pathology|May 13, 2021
Five Decades of Enucleations for Uveal Melanoma in One Center: More Tumors with High Risk Factors, No Improvement in Survival over TimeChristine D M Roelofsen, Annemijn P A Wierenga, Sjoerd van Duinen, et al.
Cancers|September 10, 2021
<i>LAG3</i> and Its Ligands Show Increased Expression in High-Risk Uveal MelanomaZahra Souri, Annemijn P A Wierenga, Wilma G M Kroes, et al.
Cancers|August 27, 2021
In Uveal Melanoma, Angiopoietin-2 but Not Angiopoietin-1 Is Increased in High-Risk Tumors, Providing a Potential Druggable TargetAnna M W Ten Voorde, Annemijn P A Wierenga, Rogier J Nell, et al.
Pharmaceuticals (Basel, Switzerland)|April 28, 2023
Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug DiscoveryJie Yin, Gangyin Zhao, Helen Kalirai, et al.
Cancers|August 27, 2021
Expression of HDACs 1, 3 and 8 Is Upregulated in the Presence of Infiltrating Lymphocytes in Uveal MelanomaZahra Souri, Aart G Jochemsen, Annemijn P A Wierenga, et al.
Cancers|August 10, 2019
Do GNAQ and GNA11 Differentially Affect Inflammation and HLA Expression in Uveal Melanoma?Christiaan van Weeghel, Annemijn P A Wierenga, Mieke Versluis, et al.
Cancers|August 27, 2021
MiRNAs Correlate with HLA Expression in Uveal Melanoma: Both Up- and Downregulation Are Related to Monosomy 3Zahra Souri, Annemijn P A Wierenga, Emine Kiliç, et al.
Cancers|July 21, 2019
Ischemia Is Related to Tumour Genetics in Uveal MelanomaNiels J Brouwer, Annemijn P A Wierenga, Gülçin Gezgin, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancers|August 10, 2019
HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological TargetZahra Souri, Annemijn P A Wierenga, Arend Mulder, et al.
International Journal of Molecular Sciences|October 1, 2020
Iris Colour and the Risk of Developing Uveal MelanomaLaurien E Houtzagers, Annemijn P A Wierenga, Aleid A M Ruys, et al.
Ocular Oncology and Pathology|May 13, 2021
Five Decades of Enucleations for Uveal Melanoma in One Center: More Tumors with High Risk Factors, No Improvement in Survival over TimeChristine D M Roelofsen, Annemijn P A Wierenga, Sjoerd van Duinen, et al.
Cancers|September 10, 2021
<i>LAG3</i> and Its Ligands Show Increased Expression in High-Risk Uveal MelanomaZahra Souri, Annemijn P A Wierenga, Wilma G M Kroes, et al.
Cancers|August 27, 2021
In Uveal Melanoma, Angiopoietin-2 but Not Angiopoietin-1 Is Increased in High-Risk Tumors, Providing a Potential Druggable TargetAnna M W Ten Voorde, Annemijn P A Wierenga, Rogier J Nell, et al.
Pharmaceuticals (Basel, Switzerland)|April 28, 2023
Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug DiscoveryJie Yin, Gangyin Zhao, Helen Kalirai, et al.
Cancers|August 27, 2021
Expression of HDACs 1, 3 and 8 Is Upregulated in the Presence of Infiltrating Lymphocytes in Uveal MelanomaZahra Souri, Aart G Jochemsen, Annemijn P A Wierenga, et al.
Cancers|August 10, 2019
Do GNAQ and GNA11 Differentially Affect Inflammation and HLA Expression in Uveal Melanoma?Christiaan van Weeghel, Annemijn P A Wierenga, Mieke Versluis, et al.
Cancers|August 27, 2021
MiRNAs Correlate with HLA Expression in Uveal Melanoma: Both Up- and Downregulation Are Related to Monosomy 3Zahra Souri, Annemijn P A Wierenga, Emine Kiliç, et al.
Cancers|July 21, 2019
Ischemia Is Related to Tumour Genetics in Uveal MelanomaNiels J Brouwer, Annemijn P A Wierenga, Gülçin Gezgin, et al.
Pageof 2